Collegium Pharmaceutical reported a gross margin of 55.18% and a net margin of -7.53% for the quarter ended Jun 2026. These financial ratios cover 47 quarters of results from Dec 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 58.49% | -4.87% | 57.90% | 42.38% | 46.33% | 35.40% | 53.47% | 54.47% | 58.75% | 63.19% | 63.11% | 62.51% | 60.76% | 54.02% | 54.75% | 57.65% | 61.70% | 62.49% | 60.59% | 55.18% | |||||||||||||||||||||||||||
| EBT Margin | 11.46% | -142.08% | -18.92% | -5.38% | 1.13% | -5.54% | -12.13% | 13.13% | 21.05% | 31.19% | 25.27% | 20.03% | 9.78% | 9.49% | 1.76% | 9.06% | 20.75% | 14.13% | 9.68% | -6.77% | |||||||||||||||||||||||||||
| EBIT Margin | 17.95% | -124.71% | -11.96% | 8.99% | 16.11% | 8.36% | 17.01% | 26.29% | 32.93% | 41.20% | 34.14% | 32.68% | 21.87% | 20.95% | 12.20% | 18.67% | 29.66% | 29.57% | 15.97% | 1.85% | |||||||||||||||||||||||||||
| EBITDA Margin | 17.95% | -124.71% | -11.96% | 8.99% | 16.11% | 8.36% | 17.01% | 26.29% | 32.93% | 41.20% | 34.14% | 32.68% | 21.87% | 20.95% | 12.81% | 19.28% | 29.66% | 29.57% | 16.20% | 2.76% | |||||||||||||||||||||||||||
| Operating Margin | 17.95% | -124.71% | -11.96% | 8.99% | 16.11% | 8.36% | 17.01% | 26.29% | 32.93% | 41.20% | 34.14% | 32.68% | 21.87% | 20.95% | 12.20% | 18.67% | 29.66% | 29.57% | 15.97% | 1.85% | |||||||||||||||||||||||||||
| Net Margin | 10.21% | -91.49% | -15.60% | -4.20% | 0.36% | -5.12% | -12.04% | 9.60% | 15.09% | 21.33% | 19.12% | 13.50% | 5.86% | 6.89% | 1.36% | 6.37% | 15.05% | 8.26% | 7.49% | -7.53% | |||||||||||||||||||||||||||
| FCF Margin | 21.53% | 130.41% | -30.36% | 32.37% | 33.58% | 46.49% | 18.99% | 73.53% | 54.10% | 48.87% | 42.35% | 46.21% | -5.80% | 46.21% | 30.72% | 38.50% | 37.38% | 59.56% | 29.37% | 35.44% | |||||||||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 18.48M | 17.38M | 48.77M | 78.96M | 71.21M | 55.58M | 39.70M | 29.46M | 30.08M | 33.23M | 31.80M | 29.57M | 32.95M | 36.80M | 36.39M | 37.68M | 38.10M | 39.48M | 41.83M | 78.00M | |||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 727.77M | 716.94M | 969.11M | 1,245.86M | 1,223.26M | 1,187.54M | 1,194.21M | 1,214.11M | 1,195.74M | 1,160.44M | 1,128.78M | 1,083.82M | 1,344.27M | 1,649.37M | 1,647.49M | 1,612.01M | 1,599.98M | 1,632.08M | 1,654.39M | 1,893.87M | |||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 373.06M | 312.95M | 824.47M | 803.30M | 780.12M | 754.92M | 716.84M | 694.04M | 628.09M | 600.48M | 582.86M | 532.76M | 864.58M | 844.16M | 834.72M | 817.44M | 844.97M | 872.79M | 876.77M | 1,164.73M | |||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.45 | 0.39 | 0.28 | 0.25 | 0.30 | 0.40 | 0.45 | 0.45 | 0.47 | 0.49 | 0.50 | 0.53 | 0.45 | 0.38 | 0.40 | 0.44 | 0.47 | 0.48 | 0.48 | 0.43 | |||||||||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | 2.77 | -7.17 | -1.72 | 0.63 | 1.07 | 0.57 | 1.15 | 1.63 | 2.17 | 3.20 | 2.85 | 3.05 | 1.89 | 1.68 | 1.04 | 1.72 | 2.85 | 3.15 | 1.95 | 0.19 | |||||||||||||||||||||||||||
| Debt Ratio | 0.16 | 0.16 | 0.50 | 0.49 | 0.49 | 0.48 | 0.44 | 0.41 | 0.38 | 0.35 | 0.32 | 0.30 | 0.39 | 0.37 | 0.37 | 0.37 | 0.35 | 0.34 | 0.34 | 0.40 | |||||||||||||||||||||||||||
| Times Interest Earned | 2.77 | -7.17 | -1.72 | 0.63 | 1.07 | 0.57 | 1.15 | 1.63 | 2.17 | 3.20 | 2.85 | 3.05 | 1.89 | 1.68 | 1.04 | 1.72 | 2.85 | 3.15 | 1.95 | 0.19 | |||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 85.37 | -25.11 | -52.85 | -116.44 | 0.00M | -109.08 | -47.61 | 57.36 | 35.81 | 30.71 | 45.81 | 53.08 | 133.41 | 71.85 | 396.83 | 77.85 | 35.09 | 86.54 | 73.93 | -78.16 | |||||||||||||||||||||||||||
| Price to SalesP/S | 8.71 | 22.98 | 8.25 | 4.89 | 4.26 | 5.58 | 5.73 | 5.50 | 5.41 | 6.55 | 8.76 | 7.16 | 7.82 | 4.95 | 5.40 | 4.96 | 5.28 | 7.15 | 5.54 | 5.89 | |||||||||||||||||||||||||||
| Price to BookP/B | 2.74 | 3.10 | 3.52 | 3.06 | 2.74 | 4.03 | 4.62 | 3.72 | 4.13 | 5.02 | 5.71 | 4.81 | 5.32 | 3.94 | 4.09 | 4.02 | 4.02 | 4.87 | 3.43 | 3.77 | |||||||||||||||||||||||||||
| Enterprise Value | 493.65M | 442.26M | 583.98M | 481.71M | 406.95M | 611.61M | 560.12M | 420.61M | 434.37M | 670.37M | 951.59M | 769.06M | 1,125.41M | 738.00M | 761.36M | 710.76M | 819.85M | 1,081.38M | 649.95M | 1,027.12M | |||||||||||||||||||||||||||
| EV to EBIT | 34.89 | -12.96 | -58.31 | 43.36 | 19.88 | 52.02 | 22.74 | 11.80 | 9.65 | 10.87 | 19.23 | 16.20 | 32.30 | 19.36 | 35.11 | 20.25 | 13.20 | 17.80 | 21.04 | 277.75 | |||||||||||||||||||||||||||
| EV to EBITDA | 34.89 | -12.96 | -58.31 | 43.36 | 19.88 | 52.02 | 22.74 | 11.80 | 9.65 | 10.87 | 19.23 | 16.20 | 32.30 | 19.36 | 33.43 | 19.61 | 13.20 | 17.80 | 20.73 | 186.41 | |||||||||||||||||||||||||||
| Market Capitalization | 686.90M | 628.68M | 690.68M | 604.43M | 541.08M | 785.30M | 829.60M | 746.08M | 738.93M | 980.91M | 1,269.64M | 1,040.69M | 1,245.37M | 900.76M | 959.13M | 932.91M | 1,105.71M | 1,468.06M | 1,071.70M | 1,176.44M | |||||||||||||||||||||||||||
| Price to FCFP/FCF | 40.46 | 17.62 | -27.17 | 15.11 | 12.68 | 12.01 | 30.17 | 7.49 | 9.99 | 13.41 | 20.69 | 15.50 | -134.74 | 10.71 | 17.57 | 12.89 | 14.13 | 12.00 | 18.85 | 16.61 | |||||||||||||||||||||||||||
| EV to FCF | 29.08 | 12.39 | -22.97 | 12.05 | 9.54 | 9.35 | 20.37 | 4.22 | 5.87 | 9.16 | 15.51 | 11.46 | -121.76 | 8.78 | 13.94 | 9.82 | 10.48 | 8.84 | 11.43 | 14.50 | |||||||||||||||||||||||||||
| EV to CFO | 28.61 | 12.22 | -23.07 | 11.91 | 9.52 | 9.22 | 20.24 | 4.22 | 5.87 | 9.14 | 15.36 | 11.41 | -125.06 | 8.72 | 13.74 | 9.81 | 10.45 | 8.79 | 11.38 | 14.40 | |||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 17.95% | -124.71% | -11.96% | 8.99% | 16.11% | 8.36% | 17.01% | 26.29% | 32.93% | 41.20% | 34.14% | 32.68% | 21.87% | 20.95% | 12.20% | 18.67% | 29.66% | 29.57% | 15.97% | 1.85% | |||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 14.55% | 4.03% | -2.28% | -2.27% | -1.55% | 4.42% | 8.70% | 11.87% | 16.01% | 23.77% | 28.11% | 32.74% | 21.87% | 14.90% | 12.24% | 11.31% | 13.69% | 15.07% | 15.49% | 12.07% | |||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 42.52% | -108.94% | 2.94% | -1.56% | -1.13% | 3.76% | 8.87% | 23.91% | 7.52% | 17.28% | 23.28% | 25.83% | 19.17% | 13.96% | 11.42% | 10.75% | 13.65% | 14.20% | 14.95% | 9.51% | |||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | 14.22% | 9.98% | 4.41% | -2.83% | -3.50% | -2.11% | -2.46% | -0.92% | 0.75% | 4.15% | 8.27% | 9.22% | 6.59% | 4.19% | 2.66% | 2.25% | 3.65% | 3.85% | 4.53% | 2.53% |